B+
Bull case
25%
Probability
Target price
$16.00
Analysis reference price unavailable
Analysis 2026-08-13 · RankAlpha Sentiment Codex
OCUL
Ocular TherapeutixCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
AXPAXLI has a potentially differentiated wet-AMD profile, a stated FDA-aligned Q4 2026 NDA path, and sufficient reported cash runway to reach important milestones. Q2 results modestly exceeded stored consensus estimates for both loss per share and revenue, but the figures come from AP/Zacks context rather than an earnings call.
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -3.0.
What can break
AXPAXLI NDA timing depends on pending clinical and regulatory evidence.
Momentum
77
Value
41
Sentiment
65
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $11.50 · Bull $16.00 · Bear $7.50Analysis 2026-08-13; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-13 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $27.17
Why
Momentum77 · Δ7d +10.3
Value41 · Δ7d 0.0
Sentiment65 · Δ7d -3.0
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta -3.0.
Contradictions & invalidation
- • AXPAXLI NDA timing depends on pending clinical and regulatory evidence.
- • Commercial launch, reimbursement, and physician adoption remain unproven.
- • The thesis remains concentrated in AXPAXLI regulatory execution and clinical validation.
Catalyst clock
2026-08-13
Q2 2026 results modestly beat stored consensus
Lead driver: Sentiment · See AI snapshot
Momentum
77
9% active weight
Current posture
7d trendImproving
Δ7d
+10.3
Δ21d
+49.9
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
65
62% active weight
Current posture
7d trendSoftening
Δ7d
-3.0
Δ21d
-2.3
Why this grade
Composite grade C. Momentum 77.1 / Value 41.2 / Sentiment 65.2
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-13. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$11.50
Analysis reference price unavailable
Analysis 2026-08-13 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$7.50
Analysis reference price unavailable
Analysis 2026-08-13 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$2.34B
Beta
0.91
Shares Out
219.62M
P/E (TTM) · Derived
-7.5
P/S (TTM)
44.11
P/FCF (TTM) · Derived
-8.92
Rev YoY
+0.1%
EPS YoY
-10.9%
Gross Margin
+87.1%
Op Margin
-603.0%
Net Debt
-$660.09M
Current Ratio
13.11
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data